Published in BMC Psychiatry on June 11, 2004
Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Ann Epidemiol (2008) 1.38
Therapist-assisted, Internet-based treatment for panic disorder: can general practitioners achieve comparable patient outcomes to psychologists? J Med Internet Res (2008) 1.03
Pharmacotherapy of panic disorder. Neuropsychiatr Dis Treat (2008) 0.81
Depression and the Link with Cardiovascular Disease. Front Psychiatry (2016) 0.80
Duration of untreated illness in panic disorder: a poor outcome risk factor? Neuropsychiatr Dis Treat (2005) 0.76
A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study. BMC Psychiatry (2009) 0.76
Remission of panic disorder with mirtazapine augmentation of paroxetine: a case report. Prim Care Companion J Clin Psychiatry (2007) 0.75
Practice guideline for the treatment of patients with panic disorder. Work Group on Panic Disorder. American Psychiatric Association. Am J Psychiatry (1998) 4.06
Antidepressants in panic disorder. J Clin Psychiatry (1997) 1.51
Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. Br J Psychiatry (1995) 1.10
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry (1998) 1.08
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull (1997) 1.06
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry (2000) 1.02
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther (1997) 1.01
A crossover study of focused cognitive therapy for panic disorder. Am J Psychiatry (1992) 0.96
SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand (2002) 0.94
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand (1997) 0.93
Panic disorder: diagnosis, epidemiology, and clinical course. J Clin Psychiatry (1996) 0.92
Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand (1997) 0.92
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders. Drugs (1998) 0.90
Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol (1987) 0.88
Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol (1995) 0.88
Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry (1999) 0.88
Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry (1998) 0.87
Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. J Clin Psychopharmacol (1992) 0.86
Efficacy studies of paroxetine in panic disorder. Psychopharmacol Bull (1998) 0.81
Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse. J Psychiatr Res (1993) 0.80
2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia. Ann Clin Psychiatry (2001) 0.80
Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Acta Psychiatr Scand Suppl (1991) 0.79
The long-term treatment of panic disorder. J Clin Psychiatry (1998) 0.79
Antidepressants in panic disorder. Int Clin Psychopharmacol (1999) 0.78
Use of benzodiazepines in panic disorder. J Clin Psychiatry (1997) 0.78
Two-year follow-up after a randomised controlled trial of self- and clinician-accompanied exposure for phobia/panic disorders. Br J Psychiatry (2001) 0.77
A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet (2002) 3.52
Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry (2009) 2.74
Security and psychiatry: the British experience and implications for forensic psychiatry services in Israel. Isr Med Assoc J (2010) 2.02
Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry (2004) 1.86
Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc Natl Acad Sci U S A (2007) 1.85
Renal insufficiency in long-term lithium treatment. J Clin Psychiatry (2004) 1.77
Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry (2003) 1.72
Addiction as a stress surfeit disorder. Neuropharmacology (2013) 1.68
Efficient vaccine against the virus causing a lethal disease in cultured Cyprinus carpio. Vaccine (2003) 1.64
Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nat Struct Mol Biol (2008) 1.64
An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model. J Mol Biol (2009) 1.62
Psychiatric admissions and hospitalization in Israel: an epidemiologic study of where we stand today and where we are going. Isr Med Assoc J (2005) 1.55
Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol (2005) 1.53
Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr Med Assoc J (2005) 1.52
Efforts to support special-needs soldiers serving in the Israeli defense forces. Psychiatr Serv (2007) 1.48
Pathological gambling: an impulse control disorder? Measurement of impulsivity using neurocognitive tests. Isr Med Assoc J (2010) 1.46
Pathogenesis of acute viral disease induced in fish by carp interstitial nephritis and gill necrosis virus. J Virol (2004) 1.36
Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction (2009) 1.32
Detection of carp interstitial nephritis and gill necrosis virus in fish droppings. Appl Environ Microbiol (2005) 1.24
Catalytic beacons for the detection of DNA and telomerase activity. J Am Chem Soc (2004) 1.21
Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry (2006) 1.17
APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. Blood (2012) 1.15
COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2004) 1.15
Go-no-go performance in pathological gamblers. Psychiatry Res (2008) 1.15
Spotlighting of cocaine by an autonomous aptamer-based machine. J Am Chem Soc (2007) 1.11
Protection of cultured Cyprinus carpio against a lethal viral disease by an attenuated virus vaccine. Vaccine (2005) 1.11
Persistence of cyprinid herpesvirus 3 in infected cultured carp cells. J Virol (2007) 1.08
Description of an as yet unclassified DNA virus from diseased Cyprinus carpio species. J Virol (2005) 1.08
Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. Int J Neuropsychopharmacol (2007) 1.05
Reduced language lateralization in first-episode schizophrenia: an fMRI index of functional asymmetry. Psychiatry Res (2009) 1.02
A virus spotlighted by an autonomous DNA machine. Angew Chem Int Ed Engl (2006) 1.00
Global functional connectivity deficits in schizophrenia depend on behavioral state. J Neurosci (2011) 0.99
Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals--preliminary report. Biol Psychiatry (2002) 0.99
Amplified chemiluminescence surface detection of DNA and telomerase activity using catalytic nucleic acid labels. Anal Chem (2004) 0.98
Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord (2010) 0.97
Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol (2005) 0.97
The effect of a series of repetitive transcranial magnetic stimulations of the motor cortex on central pain after spinal cord injury. Arch Phys Med Rehabil (2007) 0.97
Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J Clin Psychopharmacol (2005) 0.96
Characterization of a novel virus causing a lethal disease in carp and koi. Microbiol Mol Biol Rev (2006) 0.95
Comorbid cannabis use and panic disorder: short term and long term follow-up study. Hum Psychopharmacol (2004) 0.94
Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides. J Biol Chem (2007) 0.94
Staff attitudes toward patients with borderline personality disorder. Compr Psychiatry (2010) 0.94
Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol (2002) 0.93
Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif. J Mol Biol (2011) 0.93
Response to deep TMS in depressive patients with previous electroconvulsive treatment. Brain Stimul (2009) 0.93
Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord (2003) 0.93
Amantadine as augmentation therapy in the management of treatment-resistant depression. Int Clin Psychopharmacol (2003) 0.93
APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. Cancer Res (2013) 0.92
12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. J Clin Psychopharmacol (2007) 0.92
MOR: a simulation-based assessment centre for evaluating the personal and interpersonal qualities of medical school candidates. Med Educ (2008) 0.92
Deep transcranial magnetic stimulation for the treatment of auditory hallucinations: a preliminary open-label study. Ann Gen Psychiatry (2011) 0.91
Cyprinid herpes virus-3 (CyHV-3) bears genes of genetically distant large DNA viruses. FEBS Lett (2006) 0.91
Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs. J Affect Disord (2011) 0.91
Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. J Clin Psychiatry (2008) 0.90
Extended access to cocaine self-administration results in reduced glutamate function within the medial prefrontal cortex. Addict Biol (2012) 0.89
Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry (2003) 0.88
Pathological gambling: an update on neuropathophysiology and pharmacotherapy. CNS Drugs (2008) 0.88
The immediate early gene Arc is associated with behavioral resilience to stress exposure in an animal model of posttraumatic stress disorder. Eur Neuropsychopharmacol (2007) 0.88
Risk-taking decisions in pathological gamblers is not a result of their impaired inhibition ability. Psychiatry Res (2011) 0.88
Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia. Neurosci Lett (2005) 0.88
Social phobia symptoms: prevalence, sociodemographic correlates, and overlap with specific phobia symptoms. Compr Psychiatry (2006) 0.88
Coordinated and sequential transcription of the cyprinid herpesvirus-3 annotated genes. Virus Res (2012) 0.88
Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology. Schizophr Res (2004) 0.87
A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Clin Neuropharmacol (2007) 0.87
Inactivation of the dorsal raphé nucleus reduces the anxiogenic response of rats running an alley for intravenous cocaine. Pharmacol Biochem Behav (2010) 0.87
The hateful patient revisited: Relevance for 21st century medicine. Eur J Intern Med (2006) 0.87
Antibody response and resistance of Cyprinus carpio immunized with cyprinid herpes virus 3 (CyHV-3). Vaccine (2008) 0.86
Stroop performance in pathological gamblers. Psychiatry Res (2006) 0.86
[Six-month follow-up study of drug treatment for cannabis addiction: comparison study of four drugs]. Harefuah (2011) 0.86
The relationship between type of insurance, time period and length of stay in psychiatric hospitals: the Israeli case. Isr J Psychiatry Relat Sci (2010) 0.86
Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.86
Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study. J Clin Psychiatry (2002) 0.86
The utility of the Visual Analogue Scale for the assessment of depressive mood in cognitively impaired patients. Int J Geriatr Psychiatry (2004) 0.85
Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder. Prim Care Companion J Clin Psychiatry (2006) 0.85
Dual psychiatric diagnosis and substance abuse in pathological gamblers: a preliminary gender comparison study. J Addict Dis (2006) 0.85
Treatment of eating disorders improves eating symptoms but not alexithymia and dissociation proneness. Compr Psychiatry (2006) 0.84
Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study. Clin Neuropharmacol (2009) 0.84
The Positive and Negative Symptoms Questionnaire: a self-report scale in schizophrenia. Compr Psychiatry (2005) 0.84
Biosensing and probing of intracellular metabolic pathways by NADH-sensitive quantum dots. Angew Chem Int Ed Engl (2009) 0.84
Deep transcranial magnetic stimulation add-on for the treatment of auditory hallucinations: a double-blind study. Ann Gen Psychiatry (2012) 0.84
Sodium dodecyl sulphate-treated proteins as ligands in ELISA. J Immunol Methods (2002) 0.84
Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study. Hum Psychopharmacol (2004) 0.84
Tricotillomania: pathopsychology theories and treatment possibilities. Isr Med Assoc J (2012) 0.83
Kleptomania after head trauma: two case reports and combination treatment strategies. Clin Neuropharmacol (2004) 0.83
Neuropsychological mechanisms of Digit Symbol Substitution Test impairment in Asperger Disorder. Psychiatry Res (2009) 0.83
Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: a randomized double-blind placebo-controlled trial. Psychiatry Res (2010) 0.83